| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2160230 | Radiotherapy and Oncology | 2008 | 7 Pages |
Abstract
Bladder hotspot dose appears to be an important dosimetric predictor for urinary morbidity both at 3 months and at 6 months after implantation. Other predictors are prostate volume, or equivalently, the number of implanted seeds.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marcel J. Steggerda, Henk G. van der Poel, Luc M.F. Moonen,
